ALUMIS INC.
ALMS · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Schroer John R.: Form 4
Insider disclosure · Filed · Report period 02 Nov 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- ALMS · 022307102 - COMMON STOCK
Company details and SEC sources
CIK 0001847367 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ALMS on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 280 East Grand Avenue, South San Francisco, CA, 94080
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- FL2021-001, Inc. (to 19 Mar 2021)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields